Overall, MCM3 expression was positively related to TMB in 12 cancers, especially ACC, DLBC, LGG, PAAD and STAD, thus suggesting that patients with high MCM3 expression in these cancers may be more sensitive to immunotherapy. The gene discussed is MCM3; the disease is pancreatic adenocarcinoma.